Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells

Current Directions in Autoimmunity

Volumn 10, Issue , 2008, Pages 206-226

  Shiohara, T ^a   Mizukawa, Y ^a   Takahashi, R ^a   Kano, Y ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

AUTOANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE;

ANIMAL; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; DISEASE MODEL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LICHEN PLANUS; MUCOSA; PATHOLOGY; REVIEW; SKIN;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; E-SELECTIN; FUCOSYLTRANSFERASES; HUMANS; IMMUNOLOGIC MEMORY; LICHEN PLANUS; MUCOUS MEMBRANE; SKIN;

EID: 49049096003     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000131456     Document Type: Review

References (81)

1. Marrack P, Kappler J, Kotzin BL: Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905.
2. Shiohara T, Moriya N, Gotoh C, Saizawa K, Nagashima M: Locally administered monoclonal antibodies to lymphocyte function-associated antigen 1 and to L3T4 prevent cutaneous graft-vshost disease. J Immunol 1988;141:2261-2267.
3. Shiohara T, Moriya N, Saizawa K, Gotoh C, Yagita H, Nagashima M: Evidence for involvement of lymphocyte function-associated antigen 1 in T cell migration to epidermis. J Immunol 1991;146:840-845.
4. + epidermal cell numbers. J Exp Med 1990;171:1027-1041.
5. Selin LK, Welsh RM: Plasticity of T cell memory responses to viruses. Immunity 2004;20:5-16.
6. Welsh RM: Private specificities of heterologous immunity. Curr Opin Immunol 2006;18:331-337.
7. Pacegueiro W, Sachse MF, Amaro J, Farinha P, Fonseca I: Oral lichen planus versus oral lichenoid eruption as a manifestation of contact allergy. Contact Dermatitis 1999;40:333-334.
8. Yiannias JA, el-Azhary RA, Hand JH, Pakzad SY, Rogers RS: Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol 2000;42:177-182.
9. Laeigendecker R, Dekker SK, Burger PM, Mulder PGH, Van Joost T, Neumann MHA: Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol 2004;140:1434-1438.
10. Rogers RS, Bruce AJ: Lichenoid contact stomatitis: is inorganic mercury the culprit? Arch Dermatol 2004;140:1524-1525.
11. Korkij W, Chuang TY, Soltani K: Liver abnormalities in patients with lichen planus: a retrospective case-control study. J Am Acad Dermatol 1984;14:139-140.
12. Rebora A, Rongioletti F: Lichen planus and chronic active hepatitis. J Am Acad Dermatol 1984;10:840-841.
13. Criber B, Gamier C, Laustriat D, Heid E: Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994;31:1070-1072.
14. Pawlotsky J-M, Dhumeaux D, Bagot M: Hepatitis C virus in dermatology. Arch Dermatol 1995;131:1185-1193.
15. Nagao Y, Sata M, Noguchi S, Seno'o T, Kinoshita M, Kameyama T, Ueno T: Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med 2000;29:259-266.
16. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E: Oral lichen planus: different clinical features in HCV-positive and HCV-negative patients. Int J Dermatol 2000;39:134-139.
17. van der Meij EH, van der Waal I: Hepatitis C infection and oral lichen planus: a report from the Netherlands. J Oral Pathol Med 2000;29:255-258.
18. Shiohara T, Kano Y: Lichen planus and lichenoid dermatoses; in Bolognia JL, Jorizzo JL, Rapini RP (eds): Dermatology. London, Mosby, 2003, pp 175-198.
19. Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, Roggero S, Rendine S, Ghisetti V: Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 2001;144:803-808.
20. Campisi G, Di Fede O, Craxi A, Di Stefano R, Margiotta V: Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity. J Am Acad Dermatol 2004;51:364-370.
21. Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F, Carrozzo M, Mori C, Giuberti T, Ferrari C, Missale G: Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology 2002;36:1446-1452.
22. Yadav M, Arivananthan M, Chandrashekran A, Tan BS, Hashim BY: Human herpesvirus-6 (HHV-6) DNA and virus-encoded antigen in oral lesions. J Oral Pathol Med 1997;26:393-401.
23. De Vries HJ, van Marle J, Teunissen MB, Picavet D, Zorgdrager F, Bos JD, Weel J, Cornelissen M: Lichen planus is associated with human herpesvirus type 7 replication and infiltration of plasmacytoid dendritic cells. Br J Dermatol 2006;154:361-364.
24. Requena L, Kutzner H, Escalonilla P, Ortiz S, Schaller J, Rohwedder A: Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol 1998;138:161-168.
25. Al-Mutairi N, Sharma AK, Osama N-E, Joshi A, Ayman H: Isotopic cutaneous lichen planus possibly related to dental amalgam. J Am Acad Dermatol 2004;50:653-654.
26. Gibney MD, Nahass GT, Leonardi CL: Cutaneous reactions following herpes zoster infections: report of three cases and a review of the literature. Br J Dermatol 1996;134:504-509.
27. Kashima HK, Kutcher M, Kessis T, Levin LS, de Villiers EM, Shah K: Human papillomavirus in squamous cell carcinoma, leukoplakia, lichen planus, and clinically normal epithelium of the oral cavity. Ann Otol Rhinol Laryngol 1990;99:55-61.
28. Boyd AS, Annarella M, Rapini RP, Adler-Storthz K, Duvic M: False-positive polymerase chain reaction results for human papillomavirus in lichen planus. J Am Acad Dermatol 1996;35:42-46.
29. Al-Khenaizan S: Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol 2001;45:614-615.
30. Baum H, Davies H, Piekman M: Molecular mimicry in the MHC: hidden clues to autoimmunity. Immunol Today 1996;17:64-71.
31. Wucherpfennig KW: Mechanism for the induction of autoimmunity by infectious agents. J Clin Invest 2001;108:1097-1104.
32. Olsen JK, Croxfourd JL, Calenoff MA, Dal Carto MC, Miller SD: A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 2001;108:311-318.
33. Panoutsakopoulou V, Sanchirico ME, Huster KM, Jansson M, Granucci F, Shim DJ, Wucherpfennig KW, Cantor H: Analysis of the relationship between viral infection and autoimmune disease. Immunity 2001;15:137-147.
34. Mason D: A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998;19:395-404.
35. Hemmer B, Jacobsen M, Sommer N: Degeneracy in T-cell antigen recognition: implications for the pathogenesis of autoimmune diseases. J Neuroimmunol 2000;107:148-153.
36. Kissler S, Anderton SM, Wraith DC: Antigen-presenting cell activation: a link between infection and autoimmunity. J Autoimmun 2001;16:303-308.
37. Pinto JM, Marques MS, Correia TE: Lichen planus and leukocyteclastic vasculitis induced by interferon α-2b in a subject with HCV-related chronic active hepatitis. J Eur Acad Dermatol Venereol 2003;17:193-195.
38. Herra Saval A, Camancho Martinez F: Lichen planus induced by interferon-α-2B therapy in a patient with cutaneous malignant melanoma. Acta Derm Venereol 1999;79:395.
39. Wenzel J, Sheler M, Proelss J, Biever T, Tüting T: Type I interferon-associated cytotoxic inflammation in lichen planus. J Cutan Pathol 2006;33:672-678.
40. Stetson DB, Medzhitov R: Antiviral defense: interferons and beyond. J Exp Med 2006;203:1837-1841.
41. + T cells: ready for direct attack. J Exp Med 2006;203:805-808.
42. Massari LP, Kastelan M, Gruber F, Laskarin G, Tokmadzic VS, Strbo N, Zamdo G, Zavhar G: Perforin expression in peripheral blood lymphocytes and skin-infiltrating cells in patients with lichen planus. Br J Dermatol 2004;151:433-439.
43. Shiohara T, Moriya N: Epidermal T cells: their functional role and disease relevance for dermatologists. J Invest Dermatol 1997;109:271-275.
44. Scotet E, Peyrat MA, Saulquin X, Retiere C, Couedel C, Davodeau F, Dulphy N, Toubert A, Bignon JD, Lim A, Vie H, Hallet MM, Liblau R, Weber M, Berthelot JM, Houssaint E, Bonneville M: Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol 1999;29:973-985.
45. Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, Topham DJ, Pierce RH: Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol 2006;168:1169-1178.
46. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argant VP: T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigens. J Exp Med 1995;182:1703-1705.
47. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.
48. Maeda Y, Teshima T, Yamada M, Harada M: Reactivation of human herpesviruses after allogenic peripheral blood stem cell transplantation and bone marrow transplantation. Leuk Lymphoma 2000;29:229-239.
49. Yoshikawa T, Suga S, Asano Y, Nakashima Y, Yazaki T, Sobue R, Hirono M, Fududa M, Kojima S, Matsuyama T: Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991;78:1381-1384.
50. Singh N, Carrigan DR: Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Int Med 1996;124:1065-1071.
51. Sharrock CE, Kaminski E, Man S: Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990;11:281-286.
52. Sato M, Tokuda N, Fukumoto T, Mano T, Sato T, Ueyama Y: Immunohistopathological study of the oral lichenoid lesions of chronic GVHD. J Oral Pathol Med 2006;35:33-36.
53. Koelle DM, Posavad CM, Barnum GR, Johnson ML, Frank JM, Corey JM: Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Inverst 1998;101:1500-1508.
54. Shiohara T, Moriya N, Tanaka Y, Arai Y, Hayakawa J, Chiba M, Nagashima M: Immunopathologic study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells. J Am Acad Dermatol 1988;18:67-74.
55. Shiohara T, Moriya N, Nagashima M: Induction and control of lichenoid tissue reactions. Springer Semin Immunopathol 1992;13:369-385.
56. Bovenschen HJ, Seyger MMB, von Kerkhof PCM: Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 2005;153:72-78.
57. + T cells and basement membrane disruption in oral lichen planus. J Oral Pathol Med 2002;31:23-27.
58. Sugerman PB, Satterwhite K, Bigby M: Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 2000;142:449-456.
59. Teraki Y, Moriya N, Shiohara T: Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. Am J Pathol 1994;145:550-560.
60. Mizukawa Y, Yamazaki Y, Teraki Y, Hayakawa J, Hayakawa K, Nuriya H, Kohara M, Shiohara T: Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 2002;161:1337-1347.
61. Shiohara T, Mizukawa Y, Teraki Y: Pathophysiology of fixed drug eruption: the role of skinresident T cells. Curr Opin Allergy Clin Immunol 2002;2:317-323.
62. Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM: Possible role of Fas/Fas ligandmediated apoptosis in the pathogenesis of fixed drug eruption. Br J Dermatol 2006;154:419-425.
63. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
64. Mackay CR, von Adrian UH: Memory T cells - local heroes in the struggle for immunity. Science 2001;291:2323-2324.
65. Masopust D, Vezys V, Marzo AL, Leofrançois L: Preferential localization of effector memory T cells in nonlymphoid tissue. Science 2001;291:2413-2417.
66. Cambell JJ, Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000;12:336-341.
67. Kunkel EJ, Butcher EC: Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
68. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400:776-780.
69. Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M, Andrew DP, Wu L, Butcher EC, Wardlaw AJ: Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001;166:2842-2848.
70. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Muller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, Ruzicka T, Lehmann P, Oldham E, Zlotnik A: Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 2000;164:3465-3470.
71. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A: CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-165.
72. Soler D, Humphreys TL, Spinola SM, Campbell JJ: CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 2003;101:1677-1682.
73. Spandau U, Toksoy A, Goebeler M, Brocker EB, Gillitzer R: MIG is a dominant lymphocyteattractant chemokine in lichen planus lesions. J Invest Dermatol 1998;111:1003-1009.
74. + T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules. Am J Pathol 2003;163:261-268.
75. Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetsher P, Moser B: A skin-selective homing mechanisms for human immune surveillance T cells. J Exp Med 2004;199:1265-1275.
76. Wagers AJ, Waters CM, Stoolman LM, Kansas GS: Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on α1,3-fucosyltransferase VII gene expression. J Exp Med 1998;188;2225-2231.
77. Takahashi R, Mizukawa Y, Yamazaki Y, Hayakawa K, Hayakawa J, Kudo A, Shiohara T: In vitro differentiation from naïve to mature E-selectin binding CD4 T cells: acquisition of skin-homing properties occurs independently of cutaneous lymphocyte antigen expression. J Immunol 2003;171:5769-5777.
78. Smithson G, Rogers CE, Smith PL, Scheidegger EP, Petryniak B, Myers JT, Kim DS, Homeister JW, Lowe JB: Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naïve T cell trafficking to lymph nodes. J Exp Med 2001;194:601-614.
79. Homeister JW, Thall AD, Petryniak B, Maly P, Rogers CE, Smith PL, Kelly RJ, Gersten KM, Askari SW, Cheng G, Smithson G, Marks RM, Misra AK, Hindsqaul O, von Andrian UH, Lowe JB: The α(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectindependent leukocyte recruitment and lymphocyte homing. Immunity 2001;15:115-126.
80. Martinez M, Joffraud M, Giraud S, Baisse B, Bernimoulin MP, Schapira M, Spertini O: Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII. J Biol Chem 2005;280:5378-5390.
81. + regulatory T cells bear functional skin-homing receptors. J Immunol 2006;177:4488-4494.